Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2023 Filed Aug 3, 2023 13:12 UTC |
Meury WilliamDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 24,000 | $0.00 Strike: $9.47 | $0.00 |
DisclosureSEC source: 0001562180-23-006130 · primarydocument.xml · derivative · entry 7 Meury William · CIK 0001536778 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2030-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 13:12 UTC |
Meury WilliamDirector
|
SaleCommon Stock | 24,000 | $20.45 | $490,912.80 |
DisclosureSEC source: 0001562180-23-006130 · primarydocument.xml · nonDerivative · entry 6 Meury William · CIK 0001536778 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,000 F3 · price: The sale prices ranged from $20.2950 to $20.89. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 13:12 UTC |
Meury WilliamDirector
|
Exercise / conversionCommon Stock | 24,000 | $9.47 | $227,280.00 |
DisclosureSEC source: 0001562180-23-006130 · primarydocument.xml · nonDerivative · entry 5 Meury William · CIK 0001536778 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 13:12 UTC |
Meury WilliamDirector
|
SaleCommon Stock | 24,000 | $20.46 | $490,951.20 |
DisclosureSEC source: 0001562180-23-006130 · primarydocument.xml · nonDerivative · entry 4 Meury William · CIK 0001536778 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,000 F2 · price: The sale prices ranged from $20.30 to $20.97. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 13:12 UTC |
Meury WilliamDirector
|
Exercise / conversionCommon Stock | 24,000 | $7.88 | $189,120.00 |
DisclosureSEC source: 0001562180-23-006130 · primarydocument.xml · nonDerivative · entry 3 Meury William · CIK 0001536778 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 13:12 UTC |
Meury WilliamDirector
|
SaleCommon Stock | 35,000 | $20.46 | $715,946.00 |
DisclosureSEC source: 0001562180-23-006130 · primarydocument.xml · nonDerivative · entry 2 Meury William · CIK 0001536778 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,000 F1 · price: The sale prices ranged from $20.29 to $21.00. Read SEC document |
| August 02, 2023 Filed Aug 3, 2023 13:12 UTC |
Meury WilliamDirector
|
Exercise / conversionCommon Stock | 35,000 | $7.11 | $248,850.00 |
DisclosureSEC source: 0001562180-23-006130 · primarydocument.xml · nonDerivative · entry 1 Meury William · CIK 0001536778 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2023 Filed Feb 9, 2024 21:05 UTC |
Goldan Keith A.Chief Financial Officer
|
OtherCommon Stock | 862 | $18.12 | $15,619.44 |
DisclosureSEC source: 0001562180-24-001222 · primarydocument.xml · nonDerivative · entry 1 Goldan Keith A. · CIK 0001495411 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,490 F1 · kind: The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 862 shares by the Reporting Person on 07/31/2023 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 13:23 UTC |
Morrison BriggsDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 52,855 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-23-005845 · primarydocument.xml · derivative · entry 3 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,855 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 13:23 UTC |
Morrison BriggsDirector
|
SaleCommon Stock | 52,855 | $20.40 | $1,078,067.58 |
DisclosureSEC source: 0001562180-23-005845 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,836 F1 · kind: Following the sales reported in this Form 4, the Reporting Person has a total of 601,143 options to purchase shares of common stock that are vested and immediately exercisable and a total of 258,729 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $20.11 to $20.71. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 13:23 UTC |
Morrison BriggsDirector
|
Exercise / conversionCommon Stock | 52,855 | $8.77 | $463,538.35 |
DisclosureSEC source: 0001562180-23-005845 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 20:20 UTC |
Goldan Keith A.Chief Financial Officer
|
SaleCommon Stock | 577 | $22.31 | $12,872.87 |
DisclosureSEC source: 0001562180-23-005152 · primarydocument.xml · nonDerivative · entry 1 Goldan Keith A. · CIK 0001495411 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,628 F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 21:32 UTC |
Morrison BriggsDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 24,582 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001562180-23-005057 · primarydocument.xml · derivative · entry 6 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,582 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 21:32 UTC |
Morrison BriggsDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 28,273 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-23-005057 · primarydocument.xml · derivative · entry 5 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,273 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 21:32 UTC |
Morrison BriggsDirector
|
SaleCommon Stock | 28,273 | $21.18 | $598,796.69 |
DisclosureSEC source: 0001562180-23-005057 · primarydocument.xml · nonDerivative · entry 4 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,836 F1 · kind: Following the sales reported in this Form 4, the Reporting Person has a total of 643,144 options to purchase shares of common stock that are vested and immediately exercisable and a total of 269,583 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $20.94 to $21.58. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 21:32 UTC |
Morrison BriggsDirector
|
SaleCommon Stock | 24,582 | $21.18 | $520,624.64 |
DisclosureSEC source: 0001562180-23-005057 · primarydocument.xml · nonDerivative · entry 3 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,109 F1 · kind: Following the sales reported in this Form 4, the Reporting Person has a total of 643,144 options to purchase shares of common stock that are vested and immediately exercisable and a total of 269,583 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $20.94 to $21.58. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 21:32 UTC |
Morrison BriggsDirector
|
Exercise / conversionCommon Stock | 28,273 | $8.77 | $247,954.21 |
DisclosureSEC source: 0001562180-23-005057 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 21:32 UTC |
Morrison BriggsDirector
|
Exercise / conversionCommon Stock | 24,582 | $6.38 | $156,833.16 |
DisclosureSEC source: 0001562180-23-005057 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:11 UTC |
Morrison BriggsDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 52,855 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001562180-23-004032 · primarydocument.xml · derivative · entry 3 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,855 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:11 UTC |
Morrison BriggsDirector
|
SaleCommon Stock | 52,855 | $21.41 | $1,131,477.56 |
DisclosureSEC source: 0001562180-23-004032 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,836 F1 · kind: Following the sales reported in this Form 4, the Reporting Person has a total of 685,144 options to purchase shares of common stock that are vested and immediately exercisable and a total of 280,438 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $20.78 to $22.99. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:11 UTC |
Morrison BriggsDirector
|
Exercise / conversionCommon Stock | 52,855 | $6.38 | $337,214.90 |
DisclosureSEC source: 0001562180-23-004032 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:02 UTC |
Gallagher NeilPresident, Head of R&D
|
GrantStock Options (Right to buy) · Derivative | 250,000 | $19.35 Strike: $19.35 | $4,837,500.00 |
DisclosureSEC source: 0001562180-23-003520 · primarydocument.xml · derivative · entry 1 Gallagher Neil · CIK 0001972849 · President, Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2033-04-10 F1 · derivative.exercise_date: Twenty five percent (25%) of the total number of shares underlying the option shall vest on April 10, 2024, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:03 UTC |
Morrison BriggsDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 52,855 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001562180-23-003521 · primarydocument.xml · derivative · entry 3 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,855 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:03 UTC |
Morrison BriggsDirector
|
SaleCommon Stock | 52,855 | $19.53 | $1,032,237.01 |
DisclosureSEC source: 0001562180-23-003521 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,836 F1 · kind: Following the sales reported in this Form 4, the Reporting Person has a total of 727,145 options to purchase shares of common stock that are vested and immediately exercisable and a total of 291,292 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $19.28 to $20.11. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:03 UTC |
Morrison BriggsDirector
|
Exercise / conversionCommon Stock | 52,855 | $6.38 | $337,214.90 |
DisclosureSEC source: 0001562180-23-003521 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:42 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 52,854 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001562180-23-002770 · primarydocument.xml · derivative · entry 3 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,854 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:42 UTC |
Morrison BriggsDirector · President, Head of R&D
|
SaleCommon Stock | 52,854 | $22.53 | $1,190,673.77 |
DisclosureSEC source: 0001562180-23-002770 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 822,000 options to purchase shares of common stock that are vested and immediately exercisable and a total of 302,146 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $22.05 to $23.10. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:42 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionCommon Stock | 52,854 | $6.38 | $337,208.52 |
DisclosureSEC source: 0001562180-23-002770 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:09 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 7,572 | $25.84 Strike: $6.38 | $195,688.50 |
DisclosureSEC source: 0001562180-23-001533 · primarydocument.xml · derivative · entry 6 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,572 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:09 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 17,428 | $25.84 Strike: $7.20 | $450,404.00 |
DisclosureSEC source: 0001562180-23-001533 · primarydocument.xml · derivative · entry 5 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,428 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:09 UTC |
Ordentlich PeterChief Scientific Officer
|
SaleCommon Stock | 17,428 | $25.84 | $450,404.00 |
DisclosureSEC source: 0001562180-23-001533 · primarydocument.xml · nonDerivative · entry 4 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 443,841 options to purchase shares of common stock that are vested and immediately exercisable and a total of 202,500 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.53 to $26.10. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:09 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionCommon Stock | 17,428 | $7.20 | $125,481.60 |
DisclosureSEC source: 0001562180-23-001533 · primarydocument.xml · nonDerivative · entry 3 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:09 UTC |
Ordentlich PeterChief Scientific Officer
|
SaleCommon Stock | 7,572 | $25.84 | $195,688.50 |
DisclosureSEC source: 0001562180-23-001533 · primarydocument.xml · nonDerivative · entry 2 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 443,841 options to purchase shares of common stock that are vested and immediately exercisable and a total of 202,500 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.53 to $26.10. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:09 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionCommon Stock | 7,572 | $6.38 | $48,309.36 |
DisclosureSEC source: 0001562180-23-001533 · primarydocument.xml · nonDerivative · entry 1 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 5,959 | $27.64 Strike: $6.38 | $164,697.23 |
DisclosureSEC source: 0001562180-23-001118 · primarydocument.xml · derivative · entry 3 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,959 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
SaleCommon Stock | 5,959 | $27.64 | $164,697.23 |
DisclosureSEC source: 0001562180-23-001118 · primarydocument.xml · nonDerivative · entry 2 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 735,987 options to purchase shares of common stock that are vested and immediately exercisable and a total of 809,583 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $27.50 to $27.84. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 5,959 | $6.38 | $38,018.42 |
DisclosureSEC source: 0001562180-23-001118 · primarydocument.xml · nonDerivative · entry 1 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:49 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionStock Options (Right to buy) · Derivative | 52,854 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001562180-23-001117 · primarydocument.xml · derivative · entry 3 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,854 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:49 UTC |
Morrison BriggsDirector · President, Head of R&D
|
SaleCommon Stock | 52,854 | $26.83 | $1,417,908.97 |
DisclosureSEC source: 0001562180-23-001117 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 811,146 options to purchase shares of common stock that are vested and immediately exercisable and a total of 313,000 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $26.49 to $27.91. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:49 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionCommon Stock | 52,854 | $6.38 | $337,208.52 |
DisclosureSEC source: 0001562180-23-001117 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:52 UTC |
Jarrett JenniferDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000942 · primarydocument.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:00 UTC |
Goldan Keith A.Chief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 110,000 | $28.55 Strike: $28.55 | $3,140,500.00 |
DisclosureSEC source: 0001562180-23-000953 · primarydocument.xml · derivative · entry 1 Goldan Keith A. · CIK 0001495411 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2033-02-02 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:57 UTC |
Podlesak DennisDirector
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000947 · primarydocument.xml · nonDerivative · entry 1 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,763 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:52 UTC |
Katkin KeithDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000943 · primarydocument.xml · nonDerivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:54 UTC |
Legault PierreDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000944 · primarydocument.xml · nonDerivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · shares: Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:02 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
GrantStock Options (Right to buy) · Derivative | 410,000 | $28.55 Strike: $28.55 | $11,705,500.00 |
DisclosureSEC source: 0001562180-23-000956 · primarydocument.xml · derivative · entry 1 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2033-02-02 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:02 UTC |
Morrison BriggsDirector · President, Head of R&D
|
GrantStock Options (Right to buy) · Derivative | 32,000 | $28.55 Strike: $28.55 | $913,600.00 |
DisclosureSEC source: 0001562180-23-000955 · primarydocument.xml · derivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2033-02-02 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:01 UTC |
Madigan CatherineChief Medical Officer
|
GrantStock Options (Right to buy) · Derivative | 110,000 | $28.55 Strike: $28.55 | $3,140,500.00 |
DisclosureSEC source: 0001562180-23-000954 · primarydocument.xml · derivative · entry 1 Madigan Catherine · CIK 0001914577 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2033-02-02 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:59 UTC |
Ordentlich PeterChief Scientific Officer
|
GrantStock Options (Right to buy) · Derivative | 90,000 | $28.55 Strike: $28.55 | $2,569,500.00 |
DisclosureSEC source: 0001562180-23-000950 · primarydocument.xml · derivative · entry 3 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2033-02-02 F2 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:58 UTC |
Nolte AlexanderChief Accounting Officer
|
GrantStock Options (Right to buy) · Derivative | 17,000 | $28.55 Strike: $28.55 | $485,350.00 |
DisclosureSEC source: 0001562180-23-000948 · primarydocument.xml · derivative · entry 1 Nolte Alexander · CIK 0001891979 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-02-02 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly over a four-year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.